Harmony Biosciences Holdings - Plymouth Meeting, Pa., 4.7 million shares, priced $20-$23, managed by Goldman Sachs/Jefferies. Proposed Nasdaq ...
News
- Initial public offerings scheduled to debut next week
- Miami businessman pleads guilty in Vermont ski fraud case
Quiros, of Key Biscayne, Florida, and three others were indicted over a failed plan to build a biotechnology plant in Newport, Vermont, using millions ...
- Alert: Miami man pleads guilty of defrauding foreign investors in Vermont's largest fraud case, over ...
Alert: Miami man pleads guilty of defrauding foreign investors in Vermont's largest fraud case, over biotechnology plant plan. Updated 10:15 am CDT, ...
- Ocugen: 2Q Earnings Snapshot
The biotech knee implant developer posted revenue of $42,600 in the period. Its adjusted revenue was $43,000. The company's shares closed at 62 ...
- The Latest: California heat wave raises coronavirus concerns
The deals with Novavax, an American biotech company, and Janssen, a Belgian company owned by Johnson & Johnson, mean the U.K. has now ...